Edition:
United Kingdom

Arbutus Biopharma Corp (ABUS.OQ)

ABUS.OQ on NASDAQ Stock Exchange Global Select Market

4.71USD
16 Nov 2018
Change (% chg)

$0.13 (+2.84%)
Prev Close
$4.58
Open
$4.52
Day's High
$4.79
Day's Low
$4.48
Volume
82,266
Avg. Vol
124,056
52-wk High
$12.50
52-wk Low
$4.02

Chart for

About

Arbutus Biopharma Corp is a Canada-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV). The Company develops a portfolio of drug candidates with multiple... (more)
No analyst recommendations are available for .

Overall

Beta: 0.72
Market Cap(Mil.): $493.14
Shares Outstanding(Mil.): 55.03
Dividend: --
Yield (%): --

Financials

  ABUS.OQ Industry Sector
P/E (TTM): -- 31.23 33.59
EPS (TTM): -2.15 -- --
ROI: -51.57 15.57 15.05
ROE: -55.72 16.94 16.62

Earnings vs. Estimates